What does NanoLogix, Inc. do?

NanoLogix, Inc. (NNLX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is NNLX's market cap?

NanoLogix, Inc. (NNLX) has a market capitalization of approximately $9,569, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does NNLX pay a dividend?

No — NanoLogix, Inc. (NNLX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

NanoLogix, Inc. (NNLX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

NNLX

NanoLogix, Inc.

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$9.57K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.53%CAGR −65.77%

Select date range

FromTo

Sep 8, 2009Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

NNLX does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how NNLX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NNLX and 80,000+ other tickers.

About NanoLogix, Inc.

NanoLogix, Inc., a biotechnology firm, specializes in developing and providing rapid diagnostic and live cell test kits. These kits are designed to accurately detect viable bacteria and a wide array of other microorganisms. Among its key offerings are the BioNanoPore kit, which utilizes a unique water-permeable membrane capable of interacting with organic, inorganic molecules, and proteins. Another significant product is the FlatPack Petri Plate, essential for the isolation and cultivation of diverse microorganisms, including both fastidious and non-fastidious types, as well as those…

CEO: Bret T. Barnhizer
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 7
Website: nanologix.com

Peers

Peers Tab

XSNX

NovAccess Global Inc.

Cap

$12.3K

PXMD

PaxMedica, Inc. Common Stock

Latest News

News Tab

No recent news available.

Frequently Asked Questions About NNLX

What does NanoLogix, Inc. do?: NanoLogix, Inc. (NNLX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is NNLX's market cap?: NanoLogix, Inc. (NNLX) has a market capitalization of approximately $9,569, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does NNLX pay a dividend?: No — NanoLogix, Inc. (NNLX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is NNLX profitable?: NanoLogix, Inc. (NNLX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.